multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring Search Results


multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring  (Natera Inc)
90
Natera Inc multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring
Summary of Clinical Trials of drug sensitivity with <t> organoid </t> methods.
Multi Platform Profiling With Organoid Drug Sensitivity Screening And Ctdna Monitoring, supplied by Natera Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring/product/Natera Inc
Average 90 stars, based on 1 article reviews
multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Summary of Clinical Trials of drug sensitivity with organoid methods.

Journal: Frontiers in Oncology

Article Title: Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank

doi: 10.3389/fonc.2021.762184

Figure Lengend Snippet: Summary of Clinical Trials of drug sensitivity with organoid methods.

Article Snippet: Biliary Tract Cancer , Tumor resection , Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring , 20 , September 23, 2020 , Sponsor: University of Washington Collaborators: Natera, Inc. SEngine Precision Medicine, Inc. , NCT04561453/ Recruiting.

Techniques: Clinical Proteomics, Mutagenesis, Diagnostic Assay, Sampling, In Vitro, High Throughput Screening Assay, Functional Assay, Sequencing, Comparison